Frontiers of therapy for patients with heart failure

American Journal of Medicine

Volumn 126, Issue 1, 2013, Pages

  Liu, Stanley S ^a   Monti, Jennifer ^a   Kargbo, Hamid M ^a   Athar, Muhammad W ^a   Parakh, Kapil ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Pharmacologic treatment; Ventricular assist devices

Indexed keywords

ALDOSTERONE ANTAGONIST; ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ENALAPRIL; EPLERENONE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; INOTROPIC AGENT; LOOP DIURETIC AGENT; MEMBRANE METALLOENDOPEPTIDASE; METOPROLOL SUCCINATE; MILRINONE; NESIRITIDE; NEUROHORMONE; NITROPRUSSIDE SODIUM; NUCLEIC ACID; PLACEBO; PRAZOSIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; BIOMEDICAL ENGINEERING; BIVENTRICULAR PACEMAKER; BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; CELL THERAPY; COMORBIDITY; CONTINUOUS INFUSION; CYTOLOGY; DIAGNOSTIC ACCURACY; DIASTOLIC HEART FAILURE; DISEASE CLASSIFICATION; DIURETIC THERAPY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; EXERCISE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART FAILURE; HEART RHYTHM; HEART VOLUME; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPOTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR ASSIST DEVICE; LOW DRUG DOSE; META ANALYSIS; MORBIDITY; MORTALITY; NEUROMODULATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMOTE SENSING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; SYMPATHETIC FUNCTION; SYSTOLIC HEART FAILURE; ULTRAFILTRATION; UNITED STATES; VENOVENOUS ULTRAFILTRATION; VENTRICULAR PACEMAKER;

EID: 84871584928     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.04.033     Document Type: Review

References (108)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. T.E. Owan, D.O. Hodge, R.M. Herges Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
3. J. Lindenfeld, N.M. Albert, J.P. Boehmer Executive summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 2010 475 539
4. M. Gheorghiade, F. Zannad, G. Sopko Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
5. The Escape Investigators and Study Coordinators Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial JAMA 294 2005 1625 1633
6. W.T. Abraham, G.C. Fonarow, N.M. Albert Predictors of in-hospital mortality in patients hospitalized for acute heart failure J Am Coll Cardiol 52 2008 347 356
7. A. Maisel, C. Mueller, R. Nowak Mid-region prohormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
8. C. Mueller, A. Scholer, K. Laule-Kilia Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647 654
9. J.C. Jentzer, T.A. DeWald, A.F. Hernandez Combination of loop diuretics with thiazide-type diuretics in heart failure J Am Coll Cardiol 56 2010 1527 1534
10. G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
11. M.R. Costanzo, M.T. Saltzberg, M. Jessup Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD J Card Fail 16 2010 277 284
12. J.J. McMurray, J. Ostergren, K. Swedberg Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771
13. F. Zannad, J.J. McMurray, H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
14. D.N. Juurlink, M.M. Mamdani, D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551
15. H. Krum, B. Massie, W.T. Abraham Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study Eur J Heart Fail 13 2011 107 114
16. J. Gu, A. Noe, P. Chandra Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) J Clin Pharm 50 2010 401 414
17. J.G. Cleland, M. Tendera, J. Adamus The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
18. B.M. Massie, P.E. Carson, J.J. McMurray Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
19. M. Packer, M.R. Bristow, J.N. Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355
20. J.N. Cohn, G. Johnson, S. Ziesche A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
21. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
22. C.M. O'Connor, R.C. Starling, A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
23. S.S. Rathore, Y. Wang, H.M. Krumholz Sex-based differences in the effect of digoxin for the treatment of heart failure N Engl J Med 347 2002 1403 1411
24. A. Ahmed, M.W. Rich, T.E. Love Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur Heart J 27 2006 178 186
25. C.L. Tacon, J. McCaffrey, A. Delaney Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials Intensive Care Med 38 2012 359 367
26. M. Packer, J.R. Carver, R.J. Rodeheffer Effect of oral milrinone on mortality in severe chronic heart failure N Engl J Med 325 1991 1468 1475
27. G. Landoni, G. Biondi-Zoccai, M. Greco Effects of levosimendan on mortality and hospitalization A meta-analysis of randomized controlled studies Crit Care Med 40 2012 634 646
28. J.G. Cleland, J.R. Teerlink, R. Senior The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial Lancet 378 2011 676 683
29. M.A. Konstam, M. Gheorghiade, J.C. Burnett Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 2007 1319 1331
30. K.G. Haeusler, U. Laufs, M. Endres Chronic heart failure and ischemic stroke Stroke 42 2001 2977 2982
31. J.G. Cleland, I. Findlay, S. Jafri The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure Am Heart J 148 2004 157 164
32. B.M. Massie, J.F. Collins, S.E. Ammon Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial Circulation 119 2009 1616 1624
33. K. Swedberg, M. Komajda, M. Bohm Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study Lancet 376 2010 875 885
34. B.A. Borlaug, W.J. Paulus Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Eur Heart J 32 2011 670 679
35. J. Holzmeister, C. Leclercq Implantable cardioverter defibrillators and cardiac resynchronization therapy Lancet 378 2011 722 730
36. J.G. Cleland, J.C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
37. A.J. Moss, W.J. Hall, D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
38. S.A. Smith, W.T. Abraham Device therapy in advanced heart failure: what to put in and what to turn off Congest Heart Fail 17 2011 220 226
39. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
40. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
41. G. Steinbeck, D. Andresen, K. Seidl Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
42. D.J. Whellan, K.T. Ousdigian, S.M. Al-Khatib Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study J Am Coll Cardiol 55 2010 1803 1810
43. D.J. van Veldhuisen, F. Braunschweig, V. Conraads Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure Circulation 124 2011 1719 1726
44. W.T. Abraham, P.B. Adamson, R.C. Bourge Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
45. R.D. Bourge, W.T. Abraham, P.B. Adamson Randomized controlled trial of implantable continuous hemodynamic monitoring in patients with advanced heart failure: the COMPASS study J Am Coll Cardiol 51 2008 1073 1079
46. E.A. Rose, A.C. Gelijns, A.J. Moskowitz Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
47. M.S. Slaughter, J.G. Rogers, C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
48. J.K. Kirklin, D.C. Naftel, R.L. Kormos Third INTERMACS Annual Report: the evolution of destination therapy in the United States J Heart Lung Transplant 30 2011 115 123
49. V. Schachinger, S. Erbs, A. Elsasser Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 2006 1210 1221
50. G.P. Meyer, K.C. Wollert, J. Lotz Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow up data from the randomized control trial BOOST (Bone Marrow Transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 2006 1287 1294
51. E. van Rooij, W.S. Marshall, E.N. Olson Toward MicroRNA-based therapeutics for heart disease: the sense in anti-sense Circ Res 103 2008 919 928
52. C.M. O'Connor, D.J. Whellan, K.L. Lee Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial JAMA 301 2009 1439 1450
53. F. Edelmann, G. Gelbrich, H.D. Düngen Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study J Am Coll Cardiol 58 2011 1780 1791
54. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
55. L.F. Hsu, P. Jaïs, P. Sanders Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 351 2004 2373 2383
56. R.H. Jones, E.J. Velazquez, R.E. Michler Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
57. C.M. O'Connor, W. Jiang, M. Kuchibhatla Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial J Am Coll Cardiol 56 2010 692 699
58. T.D. Bradley, A.G. Logan, R.J. Kimoff Continuous positive airway pressure for central sleep apnea and heart failure N Engl J Med 353 2005 2025 2033
59. H. Teschler, M.R. Cowie, M.P. d'Ortho Rationale and design of the SERVE-HF Study: treatment of sleep-disordered breathing with predominant central sleep apnea by adaptive servo ventilation in patients with heart failure Am J Respir Crit Care Med 181 2010 A5580
60. P. Ponikowski, S. Javaheri, Michalkiewicz Transvenous phrenic stimulation for the treatment of central sleep apnea in heart failure Eur Heart J 33 2012 889 894
61. N.L. Weintraub, S.P. Collins, P.S. Pang Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association Circulation 122 19 2010 1975 1996
62. A. Nohria, S.W. Tsang, J.C. Fang Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure J Am Coll Cardiol 40 2003 1797 1804
63. G.C. Fonarow, K.F. Adams, W.T. Abraham Risk stratification for in-hospital mortality in acute decompensated heart failure: classification and regression tree analysis JAMA 293 5 2005 572 580
64. W.F. Peacock, T. DeMarco, G.C. Fonarow Cardiac troponin and outcome in acute heart failure New Engl J Med 358 2008 2117 2126
65. R.R. van Kimmenade, J.L. Januzzi Jr, P.T. Ellinor Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 6 2006 1217 1224
66. J.F. Januzzi, F. Peacocok, A.S. Maisel Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE study J Am Coll Cardiol 50 2007 607 613
67. D. Bolignano, G. Basile, P. Parisi Increased plasma neutrophil gelatinase-associated lipocalin level predicts mortality in elderly patients in chronic heart failure Rejuvenation Res 12 2009 7 14
68. C. Mueller, K. Laule-Kilia, C. Schindler Cost effectiveness of B-type natriuretic peptide in patients with acute dyspnea Ann Int Med 166 2006 1081 1087
69. J.L. Januzzi, R. van Kimmenade, J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients Eur Heart J 27 3 2006 330 337
70. H.J. Michtalik, H.C. Yeh, C.Y. Campbell Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure Am J Cardiol 107 8 2011 1191 1195
71. B.A. Bart, A. Boyle, A.J. Bank Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial J Am Coll Cardiol 46 11 2005 2043 2046
72. M.R. Costanzo, M.E. Guglin, M.T. Saltzberg Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 6 2007 675 683
73. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
74. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
75. C.B. Granger, J.J. McMurray, S. Yusuf Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 9386 2003 772 776
76. B. Pitt, F. Zannad, W. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
77. B. Pitt, W. Remme, F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
78. M. Gheorghiade, M. Albaghdadi, F. Zannad Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) Eur J Heart Fail 13 1 2011 100 106
79. S. Yusuf, M.A. Pfeffer, K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 9386 2003 777 781
80. A.S. Desai, E.F. Lewis, R. Li Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction Am Heart J 162 6 2011 966 972
81. F. Edelmann, A.G. Schmidt, G. Gelbrich Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure Eur J Heart Fail 12 8 2010 874 882
82. CIBIS-II Investigators The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 9146 1999 9 13
83. The MERIT-HF Investigators Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 9169 1999 2001 2007
84. M.D. Esler, H. Krum, P.A. Sobotka Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 9756 2010 1903 1909
85. E.J. Birks, R.S. George, M. Hedger Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study Circulation 123 4 2011 381 390
86. J.N. Cohn, G. Johnson, S. Ziesche Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure: Results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1592
87. Al Taylor, S. Ziesche, C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
88. S. Schwartzenberg, M.M. Redfield, A.M. From Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy J Am Coll Cardiol 59 5 2012 442 451
89. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 8 1997 525 533
90. P. Pullicino, J.L. Thompson, B. Barton Warfarin versus aspirin in patients with reduced cardiac ejection fraction: rationale, objective, and design J Card Fail 12 2006 39 46
91. M. Guazzi, M. Vicenzi, R. Arena Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study Circulation 124 2 2011 164 174
92. J.M. Hare, B. Mangal, J. Brown Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study J Am Coll Cardiol 51 24 2008 2301 2309
93. J.J. McMurray, J.R. Teerlink, G. Cotter Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 17 2007 2009 2019
94. M. Gheorghiade, E. Erdmann, R. Ferrari Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program - three randomized, controlled, phase IIb studies J Card Fail 17 11 2011 971-971
95. D.D. Spragg Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy J Am Coll Card 56 2010 774 781
96. H. Burger, T. Schwarz, W. Ehrlich New generation of transvenous left ventricular leads:first experience with implantation of multipolar left ventricular leads Exp Clin Cardiol 16 1 2011 23 26
97. F.Z. Khan, M.S. Virdee, J. Hutchinson Cardiac resynchronization therapy optimization using noninvasive cardiac output measurement Pacing Clin Electrophysiol 34 11 2011 1527 1536
98. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237
99. J. Brachmann, M. Bohm, K. Rybak Fluid status monitoring with a wireless network to reduce cardiovascular- related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink) Eur J Heart Fail 13 2011 796 804
100. P.B. Adamson, A. Magsieski, F. Braunschweig Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system J Am Coll Cardiol 41 2003 565 571
101. J. Ritzema, R. Troughton, I. Melton Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure Circulation 121 2010 1086 1095
102. S. Chaudhry, J.A. Mattera, J.P. Curtis Telemonitoring in patients with heart failure N Engl J Med 363 24 2010 2301 2309
103. F. Koehler, S. Winkler, M. Scheiber Telemedical interventional monitoring in heart failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design Eur J Heart Fail 12 2010 1354 1362
104. S. Mansour, D.C. Roy, V. Bouchard COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: rational and design J Cardiovasc Transl Res 3 2 2010 153 159
105. B. Assmus, J. Honold, V. Schachinger Transcoronary transplantation of progenitor cells after acute myocardial infarction New Engl J Med 355 2006 1222 1232
106. S. Janssens, C. Dubois, J. Bogaert Autologous bone marrow stem cell transfer in patients with ST-elevation myocardial infarction: a double blind, randomized controlled trial Lancet 367 2006 113 121
107. K. Lunde, S. Solheim, S. Aakhus Intraocoronary injection of mononuclear bone marrow cells in acute myocardial infarction New Engl J Med 355 2006 1199 1209
108. E.J. Velazquez, K.L. Lee, M.A. Deja Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 17 2011 1607 1616